Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
7.78
-0.62 (-7.38%)
At close: Aug 28, 2026, 4:00 PM EDT
7.85
+0.07 (0.90%)
After-hours: Aug 28, 2026, 7:30 PM EDT
Precision BioSciences Employees
Precision BioSciences had 67 employees as of June 30, 2026. The number of employees decreased by 35 or -34.31% compared to the same quarter last year.
Employees
67
Change
-35
Growth
-34.31%
Revenue / Employee
$672,463
Profits / Employee
-$787,045
Market Cap
214.74M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 67 | -35 | -34.31% |
| Mar 31, 2026 | 66 | -41 | -38.32% |
| Dec 31, 2025 | 68 | -40 | -37.04% |
| Sep 30, 2025 | 67 | -41 | -37.96% |
| Jun 30, 2025 | 102 | -8 | -7.27% |
| Mar 31, 2025 | 107 | -2 | -1.83% |
| Dec 31, 2024 | 108 | -1 | -0.92% |
| Sep 30, 2024 | 108 | -7 | -6.09% |
| Jun 30, 2024 | 110 | -82 | -42.71% |
| Mar 31, 2024 | 109 | -88 | -44.67% |
| Dec 31, 2023 | 109 | -89 | -44.95% |
| Sep 30, 2023 | 115 | -79 | -40.72% |
| Jun 30, 2023 | 192 | 0 | - |
| Mar 31, 2023 | 197 | 7 | 3.68% |
| Dec 31, 2022 | 198 | 0 | - |
| Sep 30, 2022 | 194 | -32 | -14.16% |
| Jun 30, 2022 | 192 | -44 | -18.64% |
| Mar 31, 2022 | 190 | -47 | -19.83% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Coherus Oncology | 144 |
| Voyager Therapeutics | 141 |
| Immunic | 100 |
| Keros Therapeutics | 92 |
| Acumen Pharmaceuticals | 61 |
| PepGen | 57 |
| Corbus Pharmaceuticals Holdings | 36 |
| NovaBridge Biosciences | 30 |
DTIL News
- 6 days ago - BioSciences doses first patient in Phase 1/2 FUNCTION-DMD clinical trial - TheFly
- 6 days ago - Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD Study - Business Wire
- 10 days ago - Precision BioSciences to present data from OTC-HOPE trial of ECUR-506 - TheFly
- 24 days ago - Precision BioSciences Earnings release: Q2 2026 - Filings
- 24 days ago - Precision BioSciences Quarterly report: Q2 2026 - Filings
- 24 days ago - Precision BioSciences reports Q2 EPS ($1.26) vs. ($2.13) last year - TheFly
- 24 days ago - Precision BioSciences sees cash runway through 2028 - TheFly
- 24 days ago - Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update - Business Wire